ReviewClinical transplantation and research2026

Re-engineering CD154 blockade for transplantation: Fc-free design to separate thrombotic risk from therapeutic function.

Siwon Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.